Latest News and Press Releases

Dublin, March 12, 2025 (GLOBE NEWSWIRE) -- The "Bispecific Antibody Market Opportunity, Drug Dosage, Patent, Price, Sales & Clinical Trials Insight 2030" report has been added to ...

Dublin, March 04, 2025 (GLOBE NEWSWIRE) -- The "Anti-CD38 Antibody - Pipeline Insight, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...

Dublin, Aug. 15, 2024 (GLOBE NEWSWIRE) -- The "Engineered Antibody Therapeutics for Cancer" report has been added to ResearchAndMarkets.com's offering.This study analyzes the emergence of...

Dublin, April 04, 2024 (GLOBE NEWSWIRE) -- The "Global Antibody Therapeutics Market by Format (Monoclonal, Polyclonal, Antibody Fragment, Bispecific), Disease Area (Oncology, Autoimmune &...

Crossbow Therapeutics today announced the nomination of its first development candidate, CBX-250, a T-cell engager for the treatment of myeloid leukemia.

Richmond, Feb. 22, 2024 (GLOBE NEWSWIRE) -- According to MarketDigits, Antibody Therapeutics Market was valued USD 232 Billion in 2023 and projected to reach USD 535.8 Billion by 2030, growing at a...

Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Next Generation Antibody Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology,...

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Antibody Therapeutics Market Size, Share & Trends Analysis, 2023-2030" report has been added to ResearchAndMarkets.com's offering. The...

Dublin, Jan. 05, 2024 (GLOBE NEWSWIRE) -- The "Global Antibody Therapeutic Market: Focus on Format, Disease Area, Route of Administration, End Users, Region, and Competitive Landscape - Analysis and...

Chicago, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Antibody Therapeutics market in terms of revenue was estimated to be worth $247.3 Billion in 2023 and is poised to reach $479.0 billion by 2028, growing at...